Evidence map

ReviewCurrent hypertension reports2019

Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue?

Antonis A Manolis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30826898